Filing Flows

Filing Flows › Invo Fertility (IVF) › Q1 2026

Invo Fertility (IVF) Q1 2026 earnings results (first quarter 2026)

10-Q filed Jun 22, 2026

Invo Fertility (IVF) reported revenue of $2.0M for the first quarter 2026 (Q1 2026), +23% from a year earlier and +27% from the quarter before. Operating margin was -78.9%, net loss $5.5M (274.9% of revenue).

Revenue$2.0M
Year over year+23%
Quarter over quarter+27%
Operating margin-78.9%
Net earnings−$5.5M

Invo Fertility, Q1 2026: revenue $2.0M (+23% year over year), operating margin -78.9%, net loss $5.5M, operating cash flow −$1.9M. The chart follows the revenue to costs, profit and cash.

Q1 2026AmountQ/QY/Y
Revenue$2.0M+27%+23%
Operating profit−$1.6M——
Net earnings−$5.5M-606%—
Operating cash flow−$1.9M-7703%—

What changed

Revenue was $2.0M in Q1 2026, up 23% year over year and up 27% from the previous quarter. Clinic Revenue was the largest line at 98% of revenue. Clinic Revenue added $361K year over year (up 22%), 95% of the total change.

Operating costs exceeded revenue by $1.6M, an operating margin of -78.9%. Total costs grew 27% against revenue growth of 23%. The quarter ended with a net loss of $5.5M, after a profit of $1.1M the previous quarter. Net interest and other expense of $3.9M was the main reason.

Operating cash flow was −$1.9M. Non-cash charges added back $143K of depreciation and amortization. Working capital and other items added $3.5M.

Questions

What was Invo Fertility's revenue in the first quarter 2026?

Invo Fertility (IVF) reported revenue of $2.0M for the first quarter 2026 (Q1 2026), +23% from a year earlier and +27% from the quarter before.

Was Invo Fertility profitable in the first quarter 2026?

Operating loss was $1.6M (-78.9% of revenue) and net loss $5.5M.

Open the interactive Sankey →

Source: Invo Fertility 10-Q on SEC EDGAR.